Press Release: ADC Therapeutics : ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
/PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the 24th Annual...
Read full article »
ADC Therapeutics is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers.
Read more